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Abstract
Introduction:
Arthritis rheumatoid is the most prevalent inflammatory arthritis and approximately 0.5 to I
percent of people are affected worldwide. According to the aging of the lran's population and
since the prevalence of the disease increases with aging, the assessment of the disease and its'
contributing factors and mechanisms seems to be important. Previous studies have
demonstrated the role of IGF-1 and mediating role of several cy'tokines through this growth
f'actor in relation w'ith inflammation and also demonstrated the relationship between IGF-l
and vascular endothelial dysfunction. On the other hand, recent studies have also suggested
the inflarnmatory and anti-inf'lammatorv role for interleukin 27. inhibition of immune system.
bv interleukin 35 and its anti-inflammatory effect. The curent study was designed to assess
tl.re ef'fect of aforementioned interleukins and their role in mediating IGF-t in chronic joint
inflammation and on the blood flow of chronicall,v inflamed joint rvhich are not assessed so
far.
Nlethod:
This interventional-experimental study was conducted on 144 male rats. Rats were divided
into tu,o main groups namely histopathology and blood flow assessment groups. Each group
was further divided into 9 subgroups. These subgroups were as following: control, IGF-1,IL-
27.1L-35.lGF-i antagonist. lL-27 antagonist, IL-35 antagonist. IGF-1 + IL-27 antagonist
and IGF-1 + IL-35 antagonist. Inflammation of the joint was induced bf intraarticular
injection of complete frund adjuvant. Two weeks after injecting adjur,ant (inducing chronic
inflammation): solvent or drugs were injected into the joint from day l5 to 27 in
histopathology grollps. In the day,28. the joints of rats were excised. sliced. H&E stained, and
inflammatory indices including infiltration of inflammatorl' cells. synovial hyperplasia,
villous hyperylasia" and pannus formation were assessed by Kapila method. In blood flow
group, sterile normal saline was injected into joints from da1,' 15 to 27 and in day 28. drugs
nhich r,vere disolved in physiology saline: u,ere administered topically (superfusion) to the
surface of joints and their effects on blood flou' and svstemic arterial pressure were recorded
u,ith Laser Doppler flowmetry and power-lab s1'stem respectivel)'. Furthermore, the diameter
ofjoint and weight of rats were measured during the course of experiment (28 days).
Results:
The results of the current study demonstrated that IGF- l; as a growth factor; eventually
